医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

广告
第一作者: Magdalena,Mileva
第一单位: Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.
作者单位: Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [1] Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. [2] Department of Medical Physics, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [3] Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.;Department of Radiopharmacy, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [4] Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.;Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands. [5] Department of Radiology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [6] Data Center, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [7] Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium. [8] Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium. [9] Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. [10] Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands. [11] Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.;Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands. [12] Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.;Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.;Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. [13] Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands. [14] Department of Medical Oncology, Amsterdam UMC Location VUMC, Cancer Centre Amsterdam, Amsterdam, The Netherlands. [15] Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. [16] Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. geraldine.gebhart@hubruxelles.be. [17]
DOI 10.1038/s41523-023-00610-6
PMID 38184611
发布时间 2024-01-09
提交
  • 浏览0
NPJ breast cancer

NPJ breast cancer

2024年10卷1期

4页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷